Marcel Wiesweg

German Cancer Research Center — Germany

Medicine · Health Sciences

20h-index2.7kcitations111works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(52), Cancer Genomics and Diagnostics(21), Cancer Immunotherapy and Biomarkers(20), Lung Cancer Diagnosis and Treatment(20), Colorectal Cancer Treatments and Studies(18)

Publications111 total

Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)
European Journal of Cancer·2025Open Access
Amivantamab Plus Lazertinib in Atypical <i>EGFR</i> -Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2
Journal of Clinical Oncology·2025Open Access
Improving aerobic capacity in patients with advanced non-small cell lung cancer: study protocol of the 3-armed randomized controlled BREATH trial
2025Open Access
[18F]FDG-PET/CT-based evaluation of tumor response kinetics during induction chemotherapy and concurrent radiochemotherapy in stage II - III small-cell lung cancer
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
Pathologic Complete Response Predicts Long‐Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo‐Radiotherapy in Stage‐ <scp>III</scp> Non‐Small Cell Lung Cancer
Thoracic Cancer·2025Open Access
Efficacy of targeted therapy in lung cancer with rare ALK fusions
2025Open Access
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification
npj Digital Medicine·2025· 1 citedOpen Access
P2.05.17 European Single-Center Validation of the 9Th TNM Staging System in Over 3,300 Surgically Treated NSCLC Patients
Journal of Thoracic Oncology·2025
Early years, advanced disease: The unmet need in young adults with non-small cell lung cancer
European Journal of Cancer·2025Open Access
1879P Retrospective multicenter analysis of real-world clinical data in patients with PD-L1-negative stage IV non-small cell lung cancer in Germany: “REMARCS-PD-L1-neG
Annals of Oncology·2025
Large Language Models Improve Cancer Survival Prediction Using Real-World Clinical Notes
2025Open Access
Treatment Sequences in BRAF-V600–Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy
Journal of Thoracic Oncology·2025· 11 citedOpen Access
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Non-Targeted therapy in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Thymic Epithelial Tumors
Oncology Research and Treatment·2025Open Access
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors
Med·2025· 5 citedOpen Access
Lungenkrebs bei jungen Erwachsenen ist assoziiert mit fortgeschrittenem Tumorstadium bei Erstdiagnose und erhöhter Frequenz therapeutisch adressierbarer Mutationen
Pneumologie·2025· 1 cited
PET/CT-guided immune checkpoint blocker treatment discontinuation vs. treatment continuation in lung cancer long-term responders – a National Network Genomic Medicine Lung Cancer Germany (nNGM) analysis
Nuklearmedizin - NuclearMedicine·2025Open Access
Amivantamab Plus Lazertinib vs Osimertinib in First-line EGFR-mutant Advanced NSCLC: Longer Follow-up of the MARIPOSA Study
Pneumologie·2025· 3 cited
Diffuse Lungenparenchymerkrankung nach Immuntherapie, Tyrosinkinaseinhibitoren und Antikörper-Wirkstoff-Konjugaten
Pneumologie·2025
<scp>ABO</scp>‐Blood Group Associates With Survival Outcomes in Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy
Thoracic Cancer·2025Open Access
NeoTRACK trial: Neoadjuvant TiRagolumab, Atezolizumab and Chemotherapy – dissection of IO- efficacy in NSCLC by longitudinal tracKing – protocol of a non-randomised, open-label, single-arm, phase II study
BMJ Open·2025· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Martin Schüler(42), Kaid Darwiche(22), Wilfried Eberhardt(20), Henning Reis(19), Martin Metzenmacher(18), Clemens Aigner(18), Kurt Werner Schmid(18), Martin Stuschke(17), Stefan Kasper(16), Thomas Herold(12), Dirk Theegarten(12), Hans‐Ulrich Schildhaus(10), Brigitte Schumacher(10), P. M. Markus(10), Saskia Ting(9), Ken Herrmann(8), Karl Worm(8), Martin Wermke(7), Hubertus Hautzel(7), Isabel Virchow(6)